NCT02161107View on ClinicalTrials.gov

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Seasonal Allergic RhinitisAsthma
Interventions
BIOLOGICAL

Grass-SPIRE

Intradermal injection

BIOLOGICAL

Placebo

Intradermal injection

Trial Locations (5)

K7L 2V7

Kingston General Hospital, Kingston

L5A 3V

Cheema Research Inc, Mississauga

L8P 0A1

Inflamax Research, Mississauga

K1Y 4G2

Ottawa Allergy Research Corp, Ottawa

Unknown

Centre de Recherche Appliquée en Allergie de Québec, Québec

Sponsors

Collaborators (1)

Adiga Life Sciences, Inc.
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

lead

Circassia Limited

INDUSTRY

NCT02161107 - Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma | Biotech Hunter | Biotech Hunter